UPDATE: Barclays Upgrades Teva Pharma (TEVA) to Overweight
Tweet Send to a Friend
(Updated - April 5, 2022 5:52 AM EDT)
Barclays analyst Balaji Prasad upgraded Teva Pharma (NYSE: TEVA) from Equalweight ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
Barclays analyst Balaji Prasad upgraded Teva Pharma (NYSE: TEVA) from Equalweight ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
